LL-Z1640-2

(3S,5Z,8S,9S,11E)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione

(3S,5Z,8S,9S,11E)-8,9,16-Trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecin-1,7(8H)-dion

(3S,5Z,8S,9S,11E)-8,9,16-Trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione

(3S,5Z,8S,9S,11E)-8,9,16-Trihydroxy-14-méthoxy-3-méthyl-3,4,9,10-tétrahydro-1H-2-benzoxacyclotétradécine-1,7(8H)-dione

(5S,6S,11S)-5,6,15-trihydroxy-17-methoxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),2,8,15,17-pentaene-7,13-dione

(5Z)-7-Oxozeaenol

1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,9,10-tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl-, (3S,5Z,8S,9S,11E)-

253863-19-3

5Z-7-oxozeaenol

LL-Z1640-2

MFCD12912700

(2E,5S,6S,8E,11S)-5,6,15-trihydroxy-17-methoxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,8,14,16-pentaene-7,13-dione

(2E,5S,6S,8Z,11S)-5,6,15-trihydroxy-17-methoxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),2,8,15,17-pentaene-7,13-dione

(3S,5E,8S,9S,11E)-8,9,16-Trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione

(5Z)-7-Oxo Zeaenol

58579-54-7

5E-7-oxozeaenol

66018-38-0

BMP-2-inducible protein kinase

BMP2K_HUMAN

ll z1640-2

LL-Z1640-1

NR2C2_HUMAN

TAB1_HUMAN